← Open Payments lookup

ADAM BRASKET: Open Payments

NPI 1467072132 · ANAHEIM, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,436 in 75 payments from 11 companies in 2025. Trend: 2023 $1,032 · 2024 $645 · 2025 $1,436

Food & beverage: $1,436
CompanyPaymentsAmount
ABBVIE INC.18$316
E.R. Squibb & Sons, L.L.C.19$293
Neurocrine BioSciences, Inc.10$232
Teva Pharmaceuticals USA, Inc.9$158
Otsuka America Pharmaceutical, Inc.5$123
Janssen Pharmaceuticals, Inc5$112
Alkermes, Inc.4$93
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$46
Collegium Pharmaceutical, Inc.1$23
Lundbeck LLC1$22

Products named: VRAYLAR, COBENFY, INGREZZA, AUSTEDO XR, VIVITROL, INVEGA SUSTENNA, ABILIFY ASIMTUFII, UZEDY.

Industry payments across CA — which companies pay providers there.